Comments on: Shell Partners With Codexis on Biofuel Research

By: Codexis Files for IPO, Again

Codexis Files for IPO, Again — Tue, 29 Dec 2009 00:53:16 +0000

[...] Based in Redwood City, Calif., Codexis counts oil giants Shell and Chevron among its backers, and is in the business of so-called evolved biocatalysts. The company takes a natural microbe or enzyme and shuffles the DNA sequences to create new variants, then searches for the variants best suited to the development of new, potentially cheaper drugs (Pfizer used Codexis enzymes to produce Lipitor) and non-ethanol biofuels. [...]

By: Codexis Aims to Bridge Biotech and Carbon Capture

Codexis Aims to Bridge Biotech and Carbon Capture — Wed, 16 Dec 2009 15:30:05 +0000

[...] development of new, potentially cheaper drugs (Pfizer used Codexis enzymes to produce Lipitor) and non-ethanol biofuels. This summer, the 7-year-old startup said it was looking for ways to apply this expertise to the [...]

By: Codexis IPO is Long on Promise - and Risk « Earth2Tech

Codexis IPO is Long on Promise - and Risk « Earth2Tech — Tue, 15 Apr 2008 07:00:46 +0000

[...] to Pfizer to help improve its Lipitor drug. It also sold a 13 percent stake Shell, cementing a deal to develop enzymes that can turn biomass into [...]

By: Senate Looks to Cap and Trade Carbon « Earth2Tech

Senate Looks to Cap and Trade Carbon « Earth2Tech — Thu, 08 Nov 2007 20:24:09 +0000

[...] carbon trading market is developing quickly, and everyone from energy producers to energy consumers are thinking about what a carbon-conscious market would do to their enterprise. [...]